218 related articles for article (PubMed ID: 37529322)
21. [Diversity of Lactobacillus in vagina of vulvovaginal candidiasis].
Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(13):1012-6. PubMed ID: 26506713
[TBL] [Abstract][Full Text] [Related]
22. Anti-Candida activity of beneficial vaginal lactobacilli in in vitro assays and in a murine experimental model.
De Gregorio PR; Silva JA; Marchesi A; Nader-Macías MEF
FEMS Yeast Res; 2019 Mar; 19(2):. PubMed ID: 30689833
[TBL] [Abstract][Full Text] [Related]
23. Lactobacillus johnsonii CPN23 vis-à-vis Lactobacillus acidophilus NCDC15 Improves Gut Health, Intestinal Morphometry, and Histology in Weaned Wistar Rats.
Kumar S; Pattanaik AK; Jadhav SE; Jangir BL
Probiotics Antimicrob Proteins; 2024 Apr; 16(2):474-489. PubMed ID: 36976517
[TBL] [Abstract][Full Text] [Related]
24. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
Ray A; Ray S; George AT; Swaminathan N
Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970
[TBL] [Abstract][Full Text] [Related]
25. Vaginal prevention of Candida albicans: synergistic effect of lactobacilli and mannan oligosaccharides (MOS).
Faustino M; Pereira JO; Pereira AM; Oliveira AS; Ferreira CMH; Pereira CF; Durão J; Pintado ME; Carvalho AP
Appl Microbiol Biotechnol; 2024 Dec; 108(1):73. PubMed ID: 38194142
[TBL] [Abstract][Full Text] [Related]
26. Development of probiotic loaded multilayer microcapsules incorporated into dissolving microneedles for potential improvement treatment of vulvovaginal candidiasis: A proof of concept study.
Kristina Enggi C; Sulistiawati S; Stephanie S; Tangdilintin F; Anas Achmad A; Adelia Putri R; Burhanuddin H; Arjuna A; Manggau MA; Dian Permana A
J Colloid Interface Sci; 2023 Oct; 648():203-219. PubMed ID: 37301145
[TBL] [Abstract][Full Text] [Related]
27. Antifungal and Antivirulence Activity of Vaginal
Itapary Dos Santos C; Ramos França Y; Duarte Lima Campos C; Quaresma Bomfim MR; Oliveira Melo B; Assunção Holanda R; Santos VL; Gomes Monteiro S; Buozzi Moffa E; Souza Monteiro A; Andrade Monteiro C; Monteiro-Neto V
Pathogens; 2019 Sep; 8(3):. PubMed ID: 31547398
[No Abstract] [Full Text] [Related]
28. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
Martinez RC; Seney SL; Summers KL; Nomizo A; De Martinis EC; Reid G
Microbiol Immunol; 2009 Sep; 53(9):487-95. PubMed ID: 19703242
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomics Reveals Effect of
Wu H; Li C; Wang Y; Zhang M; Wu D; Shao J; Wang T; Wang C
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794163
[TBL] [Abstract][Full Text] [Related]
30. In vitro probiotic properties of vaginal Lactobacillus fermentum MG901 and Lactobacillus plantarum MG989 against Candida albicans.
Kang CH; Kim Y; Han SH; Kim JS; Paek NS; So JS
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():232-237. PubMed ID: 30014929
[TBL] [Abstract][Full Text] [Related]
31. Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment.
Russo R; Superti F; Karadja E; De Seta F
Mycoses; 2019 Apr; 62(4):328-335. PubMed ID: 30565745
[TBL] [Abstract][Full Text] [Related]
32. [Changes of local vaginal immune regulation in rats infected with vulvovaginal candidiasis].
Chen X; Li T; Wang FJ; Shang CG; Zhang X; Bai HH; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):330-337. PubMed ID: 31154715
[No Abstract] [Full Text] [Related]
33. Vaginal lactobacilli inhibit growth and hyphae formation of Candida albicans.
Jang SJ; Lee K; Kwon B; You HJ; Ko G
Sci Rep; 2019 May; 9(1):8121. PubMed ID: 31148560
[TBL] [Abstract][Full Text] [Related]
34. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
[TBL] [Abstract][Full Text] [Related]
35. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
Chen Z; Jin J; Chen H; Chen Y; Feng S
Microb Pathog; 2023 Apr; 177():106037. PubMed ID: 36842517
[TBL] [Abstract][Full Text] [Related]
36. Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32.
Hsieh PS; Tsai YC; Chen YC; Teh SF; Ou CM; King VA
Helicobacter; 2012 Dec; 17(6):466-77. PubMed ID: 23067294
[TBL] [Abstract][Full Text] [Related]
37. Low intensity ultrasound-mediated drug-loaded nanoparticles intravaginal drug delivery: an effective synergistic therapy scheme for treatment of vulvovaginal candidiasis.
Yang M; Cao Y; Zhang Z; Guo J; Hu C; Wang Z; Du Y
J Nanobiotechnology; 2023 Feb; 21(1):53. PubMed ID: 36782198
[TBL] [Abstract][Full Text] [Related]
38. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice.
Shao MK; Qi WJ; Hou MY; Luo DD
J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814
[TBL] [Abstract][Full Text] [Related]
39. [Effects of antimicrobial peptide LL-37 expressed and purified from prokaryotes in the murine model of vaginal candidiasis].
Wang F; Huo Y; Yin LR; Sun B; Zhang PP
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):530-4. PubMed ID: 27465873
[TBL] [Abstract][Full Text] [Related]
40. Recurrent Vulvovaginal Candidiasis: a Dynamic Interkingdom Biofilm Disease of
McKloud E; Delaney C; Sherry L; Kean R; Williams S; Metcalfe R; Thomas R; Richardson R; Gerasimidis K; Nile CJ; Williams C; Ramage G
mSystems; 2021 Aug; 6(4):e0062221. PubMed ID: 34374560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
